Barclays PLC Seer, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Seer, Inc. stock. As of the latest transaction made, Barclays PLC holds 50,424 shares of SEER stock, worth $87,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,424

Previous 64,426 21.73%

Holding current value

$87,737

Previous $127,000 8.66%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.85 - $2.55 $25,903 - $35,705	-14,002 Reduced 21.73%	50,424 $116,000
Q3 2024 Nov 15, 2024	BUY	$1.59 - $2.07 $26,047 - $33,910	16,382 Added 34.1%	64,426 $127,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.24 $42,822 - $58,134	-25,953 Reduced 35.07%	48,044 $80,000
Q1 2024 May 15, 2024	SELL	$1.54 - $2.09 $60,769 - $82,473	-39,461 Reduced 34.78%	73,997 $141,000
Q4 2023 Feb 15, 2024	BUY	$1.47 - $2.22 $103,182 - $155,826	70,192 Added 162.23%	113,458 $220,000
Q3 2023 Nov 07, 2023	BUY	$2.18 - $5.52 $61,380 - $155,421	28,156 Added 186.34%	43,266 $96,000
Q2 2023 Aug 03, 2023	SELL	$3.16 - $4.96 $83,698 - $131,375	-26,487 Reduced 63.68%	15,110 $64,000
Q1 2023 May 04, 2023	BUY	$3.6 - $5.88 $77,986 - $127,378	21,663 Added 108.67%	41,597 $160,000
Q4 2022 Feb 13, 2023	BUY	$5.03 - $8.58 $88,764 - $151,411	17,647 Added 771.62%	19,934 $116,000
Q3 2022 Nov 03, 2022	SELL	$7.7 - $13.31 $2.9 Million - $5.01 Million	-376,186 Reduced 99.4%	2,287 $18,000
Q2 2022 Aug 12, 2022	SELL	$6.72 - $16.07 $6.24 Million - $14.9 Million	-928,861 Reduced 71.05%	378,473 $3.39 Million
Q1 2022 May 16, 2022	BUY	$11.88 - $23.4 $15.5 Million - $30.6 Million	1,307,334 New	1,307,334 $19.9 Million

Others Institutions Holding SEER

# of Institutions

Shares Held

34.6M

Call Options Held

Put Options Held

1.2K

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $102M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account